October212013

Personalis Launches the ACE Clinical Exome™

Personalis introduces the first test to combine an enhanced clinical exome with genome-wide structural variant detection
October072013

Personalis Closes $22M Series B Financing

Personalis, Inc., the leading provider of advanced medical exome and genome sequencing and interpretation services, announced today the closing of a $22 million Series B financing...
June302013

Personalis Co-Founder Dr. Atul Butte MD, Stanford University, Recognized at the White House

Key genome interpretation technology developed by Dr. Butte’s lab is being commercialized by Personalis, Inc., under exclusive license.
June042013

Personalis Announces Participation in the European Society of Human Genetics Conference

Services for researchers engaging in case-control, family-based, or proband-only genome studies of disease and pharmacogenomics
May072013

Personalis Announces Illumina CSPro Certification for Sequencing

Personalis announced today that it has successfully completed IlluminaCSPro™ certification for sequencing on HiSeq and MiSeq...
April302013

Michael Fitzpatrick joins Personalis as Vice President Worldwide Sales

Personalis today announced the appointment of Michael Fitzpatrick as Vice President Worldwide Sales. Mr. Fitzpatrick brings substantial experience in sales and sales operations in the life science industry...
March112013

Personalis Awarded Contract from VA Million Veteran Program – Whole Genome Sequencing and Data Analysis for Over 1,000 Individuals

The US Department of Veterans Affairs (VA) has awarded its first contract for whole genome DNA sequencing and data analysis to Personalis, Inc...
February142013

Personalis Introduces Genome Services for Research – High Accuracy Sequencing and Interpretation of Human Genomes

Services for researchers engaging in case-control, family-based, or proband-only genome studies of disease, pharmacogenomics, and cancer